Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Inhaltsangabe
One: Pathophysiology.- 1. Role of cell culture in the management of haematological diseases.- 2. Oxygen transport to the tissue and blood viscosity.- 3. Infection prevention in neutropenic patients.- 4. Apheresis units: designs and future applications.- 5. Platelets for transfusion: collection, storage and clinical efficacy.- 6. Leukapheresis: clinical experience and post-transfusion control.- 7. Plasma proteins for therapeutic use: past, present and future.- 8. Clinical significance of tissue antigens.- 9. Clinical significance of red cell blood groups.- 10. The crossmatch: how much is enough?.- 11. Isoimmunisation in pregnancy: diagnosis, treatment and prevention.- 12. Immune plasma for immunoglobulin.- Two: Clinical Practice.- 1. Blood and blood components: uses and abuses.- 2. Massive transfusion and its effects in clinical practice.- 3. Diagnosis of bleeding disorders.- 4. Treatment of the haemophilias.- 5. Advances in the treatment of thrombocytopenia.- 6. Red cell therapy.- 7. Blood transfusion in sickle cell disease.- 8. Supportive care in leukemia treatment.- 9. Immunosuppression and oncology.- 10. Use of immunoglobulins.- 11. Bone marrow transplantation (BMT).- 12. Transfusion support and obstetrical haemorrhage.- 13. Cardiac operations and transfusion requirements.- 14. Supportive therapy for liver transplantation.- 15. Supportive therapy in the new born.- 16. Therapeutic plasma exchange.- 17. Transfusion related morbidity and mortality in the intensive care facility.- 18. Infections transmitted by blood transfusion.- Three: Future Trends.- 1. Hepatitis B in pregnancy.- 2. Interferons: past, present and future.- 3. The use of antibody in the malignant blood diseases.- 4. Therapeutic approaches to abnormalities of blood rheology in vascular disease.- 5. Can wesupport comprehensive home care for haemophiliacs?.- 6. Transfusion support in a community disaster.- 7. Comprehensive haemotherapy program for developing countries.- 8. Artificial blood substitutes.
One: Pathophysiology.- 1. Role of cell culture in the management of haematological diseases.- 2. Oxygen transport to the tissue and blood viscosity.- 3. Infection prevention in neutropenic patients.- 4. Apheresis units: designs and future applications.- 5. Platelets for transfusion: collection, storage and clinical efficacy.- 6. Leukapheresis: clinical experience and post-transfusion control.- 7. Plasma proteins for therapeutic use: past, present and future.- 8. Clinical significance of tissue antigens.- 9. Clinical significance of red cell blood groups.- 10. The crossmatch: how much is enough?.- 11. Isoimmunisation in pregnancy: diagnosis, treatment and prevention.- 12. Immune plasma for immunoglobulin.- Two: Clinical Practice.- 1. Blood and blood components: uses and abuses.- 2. Massive transfusion and its effects in clinical practice.- 3. Diagnosis of bleeding disorders.- 4. Treatment of the haemophilias.- 5. Advances in the treatment of thrombocytopenia.- 6. Red cell therapy.- 7. Blood transfusion in sickle cell disease.- 8. Supportive care in leukemia treatment.- 9. Immunosuppression and oncology.- 10. Use of immunoglobulins.- 11. Bone marrow transplantation (BMT).- 12. Transfusion support and obstetrical haemorrhage.- 13. Cardiac operations and transfusion requirements.- 14. Supportive therapy for liver transplantation.- 15. Supportive therapy in the new born.- 16. Therapeutic plasma exchange.- 17. Transfusion related morbidity and mortality in the intensive care facility.- 18. Infections transmitted by blood transfusion.- Three: Future Trends.- 1. Hepatitis B in pregnancy.- 2. Interferons: past, present and future.- 3. The use of antibody in the malignant blood diseases.- 4. Therapeutic approaches to abnormalities of blood rheology in vascular disease.- 5. Can wesupport comprehensive home care for haemophiliacs?.- 6. Transfusion support in a community disaster.- 7. Comprehensive haemotherapy program for developing countries.- 8. Artificial blood substitutes.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
